Please login to the form below

5 strategies that will improve your clinical trial recruitment

Let’s take a look at strategies you can use to improve your clinical trial recruitment today

Strategy #1: Make your patients the centre of everything

I cannot stress this enough. At every phase of your clinical trial development, everything you put in place needs to be based on patients’ needs. What the patient wants and needs should be built into the foundation of your study’s design, including the endpoints that are truly meaningful to them. A previous blog discusses in detail how to hear and use the patient voice to develop a clinical trial that works for them, and in turn, work for you.

If you’re working with a patient recruitment company, the needs of your patients should be their number one focus when creating outreach materials and targeting strategies. Here’s what to look out for:

  • Outreach approaches should be tailored to the trial condition area
  • The materials they create should reflect the patient population
  • They should be responsive to patients, and use social media and email to answer questions about the trial
  • Find out if they have relationships with patient advocates that they can utilise
  • Consider the methods they use to engage patients, are they right for your study?

Strategy #2: Reach out to local healthcare providers and patient advocates

Don’t underestimate the relationships patients have with their primary healthcare providers. They’re the people who have likely seen patients through any ailment they’ve ever had, and who they feel will understand their health better than anyone else. So, with that in mind, your trial should also provide outreach materials specifically for healthcare providers, too. Making sure they know about your clinical trial, understand it, and are confident in recommending it, can be really beneficial to engaging with the right patients.

Got connections with local hospitals, patient advocates, or non-profit organisations? Then use your network to get the word out there about your trial. Advocacy groups can be a huge help to your clinical trial recruitment. Mainly because that trust is already there. And not only will they help get your trial in front of patients, they have a deep understanding of the needs of their members. They can even show you what needs aren’t being met so you can go ahead and be the ones to meet them. Plus, their relationship with patients can be really helpful in developing new methods of engaging patients in research.

Strategy #3: Be where your patients are

Now more than ever, patients, in fact everyone, are spending their time online. So, that’s where you need to be. Digital patient recruitment campaigns should be your marketing focus right now. You want your clinical trial information to be all over Facebook, Twitter, Quora, TikTok, Reddit, Pinterest, Google, Bing… essentially wherever patients could be spending their time now. But to really make sure that your digital advertising will be seen by the right people, you’re going to want to take advantage of interest and keyword targeting, which works by finding patients who are actively searching for treatment options for their conditions.

Strategy #4: Save time and improve patient morale by screening for multiple trials

A simple way to save time and money is to screen for all trials in the same condition area at once. It’s also a good way to help increase patients’ chances of qualifying for a trial. This is a big benefit as patients being told that they don’t qualify for a trial they want to take part in, could put them off trying to sign up for others. But screening for multiple trials at once would hopefully increase their chances of qualifying. It’s win-win for everyone.

Multiple trial screening can be made easier by working with a patient recruitment company. They should develop online pre-screeners that direct patients based on their location and responses to the inclusion and exclusion criteria questions.

Strategy #5: Follow up with patients or be forgotten

Making patients feel important and front of mind needs to start even before they become participants. If patients are unsure about taking the leap and signing up, or if they’ve been too busy, following up with them could give them the nudge they need. Automated emails or texts can make sure patients know that you haven’t forgotten about them, and that your trial isn’t forgotten about.

Following up with patients should continue throughout the study to help reduce drop outs. A solid patient retention strategy is just as important as your recruitment strategy (another previous blog looks at this in detail here) and should be part of your trial’s patient-centric design, which takes us full circle to strategy #1.

This blog was originally published here.

19th March 2021



Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Suite 2.10, Jactin House
24 Hood Street
M4 6WX
United Kingdom

Latest content on this profile

Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient community, we’re proud to launch a series of emotive videos that help give PH patients a voice and the chance to share their experiences.
COUCH Health
What you can do to help make invisible illnesses more visible?
Before we begin, you might be wondering what exactly an invisible illness is. An invisible illness is an umbrella term for any medical condition that isn't easily visible to others. This can include chronic physical conditions like arthritis and diabetes, or mental illnesses.
COUCH Health
Training for PI's and study staff has to change now
We need to make sure sites receive training that truly focuses on meeting needs.
COUCH Health
#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial release, “The Reporting of Race and Ethnicity in Medical and Science Journals”. Substantial changes have been made in the race/ethnicity data section. But what does this mean?
COUCH Health
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?
COUCH Health
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities in representation in COVID-19 clinical trials?
COUCH Health